These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26877251)

  • 1. Strategies to target long-lived plasma cells for treating hemophilia A inhibitors.
    Liu CL; Lyle MJ; Shin SC; Miao CH
    Cell Immunol; 2016 Mar; 301():65-73. PubMed ID: 26877251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term tolerance to factor VIII is achieved by administration of interleukin-2/interleukin-2 monoclonal antibody complexes and low dosages of factor VIII.
    Liu CL; Ye P; Lin J; Djukovic D; Miao CH
    J Thromb Haemost; 2014 Jun; 12(6):921-31. PubMed ID: 24684505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-CD20 as the B-Cell Targeting Agent in a Combined Therapy to Modulate Anti-Factor VIII Immune Responses in Hemophilia a Inhibitor Mice.
    Liu CL; Ye P; Lin J; Butts CL; Miao CH
    Front Immunol; 2014 Jan; 4():502. PubMed ID: 24432019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dataset from administration of single or combined immunomodulation agents to modulate anti-FVIII antibody responses in FVIII plasmid or protein primed hemophilia A mice.
    Liu CL; Lyle MJ; Shin SC; Miao CH
    Data Brief; 2016 Jun; 7():973-80. PubMed ID: 27081675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
    Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
    Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo expansion of regulatory T cells with IL-2/IL-2 mAb complexes prevents anti-factor VIII immune responses in hemophilia A mice treated with factor VIII plasmid-mediated gene therapy.
    Liu CL; Ye P; Yen BC; Miao CH
    Mol Ther; 2011 Aug; 19(8):1511-20. PubMed ID: 21468007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR4-CXCL12 interaction is important for plasma cell homing and survival in NZB/W mice.
    Cheng Q; Khodadadi L; Taddeo A; Klotsche J; F Hoyer B; Radbruch A; Hiepe F
    Eur J Immunol; 2018 Jun; 48(6):1020-1029. PubMed ID: 29427452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Treg-Selective IL-2 Mutein Prevents the Formation of Factor VIII Inhibitors in Hemophilia Mice Treated With Factor VIII Gene Therapy.
    Chen AC; Cai X; Li C; Khoryati L; Gavin MA; Miao CH
    Front Immunol; 2020; 11():638. PubMed ID: 32411127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist.
    Broxmeyer HE; Orschell CM; Clapp DW; Hangoc G; Cooper S; Plett PA; Liles WC; Li X; Graham-Evans B; Campbell TB; Calandra G; Bridger G; Dale DC; Srour EF
    J Exp Med; 2005 Apr; 201(8):1307-18. PubMed ID: 15837815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerogenic nanoparticles to induce immunologic tolerance: Prevention and reversal of FVIII inhibitor formation.
    Zhang AH; Rossi RJ; Yoon J; Wang H; Scott DW
    Cell Immunol; 2016 Mar; 301():74-81. PubMed ID: 26687613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of activated T follicular helper cells is critical for anti-FVIII inhibitor development in hemophilia A mice.
    Jing W; Chen J; Cai Y; Chen Y; Schroeder JA; Johnson BD; Cui W; Shi Q
    Blood Adv; 2019 Oct; 3(20):3099-3110. PubMed ID: 31648333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulation for inhibitors in hemophilia A: the important role of Treg cells.
    Miao CH
    Expert Rev Hematol; 2010 Aug; 3(4):469-83. PubMed ID: 20976115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients.
    Whelan SF; Hofbauer CJ; Horling FM; Allacher P; Wolfsegger MJ; Oldenburg J; Male C; Windyga J; Tiede A; Schwarz HP; Scheiflinger F; Reipert BM
    Blood; 2013 Feb; 121(6):1039-48. PubMed ID: 23243272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralisation of factor VIII inhibitors by anti-idiotypes isolated from phage-displayed libraries.
    Schmidt A; Brettschneider K; Kahle J; Orlowski A; Becker-Peters K; Stichel D; Schulze J; Braner M; Tampé R; Schwabe D; Königs C
    Thromb Haemost; 2016 Jul; 116(1):32-41. PubMed ID: 27009573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulation of transgene responses following naked DNA transfer of human factor VIII into hemophilia A mice.
    Miao CH; Ye P; Thompson AR; Rawlings DJ; Ochs HD
    Blood; 2006 Jul; 108(1):19-27. PubMed ID: 16507778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerating Factor VIII: Recent Progress.
    Lacroix-Desmazes S; Voorberg J; Lillicrap D; Scott DW; Pratt KP
    Front Immunol; 2019; 10():2991. PubMed ID: 31998296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy for inhibitor reversal in haemophilia A using monoclonal anti-CD20 and rapamycin.
    Biswas M; Rogers GL; Sherman A; Byrne BJ; Markusic DM; Jiang H; Herzog RW
    Thromb Haemost; 2017 Jan; 117(1):33-43. PubMed ID: 27683758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance induction in hemophilia A animal models: battling inhibitors with antigen-specific immunotherapies.
    Adair P; Su Y; Scott DW
    Discov Med; 2013 May; 15(84):275-82. PubMed ID: 23725600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic stem cells encoding porcine factor VIII induce pro-coagulant activity in hemophilia A mice with pre-existing factor VIII immunity.
    Doering CB; Gangadharan B; Dukart HZ; Spencer HT
    Mol Ther; 2007 Jun; 15(6):1093-9. PubMed ID: 17387335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene Delivery of Activated Factor VII Using Alternative Adeno-Associated Virus Serotype Improves Hemostasis in Hemophiliac Mice with FVIII Inhibitors and Adeno-Associated Virus Neutralizing Antibodies.
    Sun J; Hua B; Chen X; Samulski RJ; Li C
    Hum Gene Ther; 2017 Aug; 28(8):654-666. PubMed ID: 28478688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.